Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

189

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D01AC01	CANESTEN	B	Clotrimazole - 0.01g/ml	0.01g/ml	Solution	368,213 L.L
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	21,354,452 L.L
L04AA42	MAYZENT	B	Siponimod - 0.25mg	0.25mg	Tablet, film coated	15,102,158 L.L
A03AX13	MOSAR PLUS	B	Mosapride citrate - 5mg, Simethicone - 200mg		Tablet, coated	865,435 L.L
A12AX	CI-CAL+D	B	Calcium citrate - 250mg, Vitamin D3 - 1,000IU		Tablet	1,118,077 L.L
D01AC01	CANESTEN	B	Clotrimazole - 0.01g/g	0.01g/g	Cream	344,024 L.L
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	21,354,452 L.L
L04AA42	MAYZENT	B	Siponimod - 0.25mg	0.25mg	Tablet, film coated	124,258,444 L.L
N04BB01	PK-MERZ	B	Amantadine (sulfate) - 100mg	100mg	Tablet, film coated	1,382,814 L.L
A03AX13	OVOL FOR GAZ	B	Simethicone - 180mg	180mg	Capsule, liquid gel	241,892 L.L
A12AX	CI-CAL+D	B	Calcium citrate - 250mg, Vitamin D3 - 800IU		Tablet, chewable	804,962 L.L
D01AC02	DAKTARIN	B	Miconazole nitrate - 20mg/g	20mg/g	Cream	231,141 L.L
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	3,420,079 L.L
J01XX08	ZYVOX IV	B	Linezolide - 600mg/300ml	600mg/300ml	Injectable solution	4,414,523 L.L
L01BA04	ALIMTA	B	Pemetrexed (disodium) - 100mg	100mg	Injectable concentrated powder for solution	16,854,009 L.L
L04AA42	MAYZENT	B	Siponimod - 2mg	2mg	Tablet, film coated	124,258,444 L.L
N04BB01	SYMMETREL	B	Amantadine - 100mg	100mg	Capsule	568,253 L.L
N06AX11	REMERON SOLTAB	B	Mirtazapine - 30mg	30mg	Tablet, orodispersible	1,486,290 L.L
L04AA10	RAPAMUNE	B	Sirolimus - 1mg	1mg	Tablet	L.L
A03AX58	METEOSPASMYL	B	Alverine citrate - 60mg, Simethicone - 300mg		Capsule	481,096 L.L
C07AB07/C09CA	CONCOR T 2.5	B	Bisoprolol fumarate - 2.5mg, Telmisartan - 40mg		Tablet	1,163,209 L.L
C09DA06	BLOPRESS PLUS 8MG	B	Candesartan cilexetil - 8mg, Hydrochlorothiazide - 12.5mg		Tablet	1,060,292 L.L
H02AB01	DIPROFOS	B	Betamethasone (dipropionate) - 5mg/ml, Betamethasone (sodium phosphate) - 2mg/ml		Injectable suspension	446,156 L.L
L04AA44	RINVOQ	B	Upadacitinib - 15mg	15mg	Tablet, prolonged release	45,469,094 L.L
M01AH05	ARCOXIA	B	Etoricoxib - 60mg	60mg	Tablet, film coated	1,685,178 L.L
N04BC05	SIFROL	B	Pramipexole (dihydrochloride monohydrate) - 0.18mg	0.18mg	Tablet	631,606 L.L
C07AB07/C09CA	CONCOR T 2.5	B	Bisoprolol fumarate - 2.5mg, Telmisartan - 40mg		Tablet	2,209,797 L.L
H02AB02	DECADRON	B	Dexamethasone - 0.5mg/5ml	0.5mg/5ml	Elixir	449,227 L.L
N06AX16	EFEXOR XR	B	Venlafaxine (HCl) - 75mg	75mg	Capsule, sustained release	732,394 L.L
L04AA18	CERTICAN	B	Everolimus - 0.5mg	0.5mg	Tablet	L.L

...

189